31073 Tirzepatide for Sale
Reliable Manufacturer Supply Tirzepatide Peptide Meet Global Lab Research Raw Material Demand CAS 2023788-19-2
-
Price:
$8/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg*10vials,10mg*10vials,15mg*10vials,20mg*10vials,30mg*10vials,40mg*10vials,60mg*10vials
Quick Reconstitution Tirzepatide Lyophilized Cake Clean Clear Solution After Dissolving Lab Test Raw Material CAS 2023788-19-2
-
Price:
$8/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg*10vials,10mg*10vials,15mg*10vials,20mg*10vials,30mg*10vials,40mg*10vials,60mg*10vials
High Biological Activity Tirzepatide Lyophilized Peptide Maintain Potency After Long Distance International Transport
-
Price:
$8/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg*10vials,10mg*10vials,15mg*10vials,20mg*10vials,30mg*10vials,40mg*10vials,60mg*10vials
High Activity Tirzepatide Lyophilized Peptide Superior Glycemic Control Raw Material for Institutional Laboratory Use CAS 2023788-19-2
-
Price:
$8/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg*10vials,10mg*10vials,15mg*10vials,20mg*10vials,30mg*10vials,40mg*10vials,60mg*10vials
Prediabetes Intervention Research Tirzepatide Dual GLP1 GIP Peptide Raw Material Strict Purity Monitoring CAS 2023788-19-2
-
Price:
$8/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg*10vials,10mg*10vials,15mg*10vials,20mg*10vials,30mg*10vials,40mg*10vials,60mg*10vials
Products You May Be Interested in
Strict Impurity Control Tirzepatide Synthetic Peptide Reduce Related Substances For Accurate Lab Experimental Results
-
Price:
$8/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg*10vials,10mg*10vials,15mg*10vials,20mg*10vials,30mg*10vials,40mg*10vials,60mg*10vials
Sterile Vial Packaging Tirzepatide Synthetic Peptide Avoid Contamination During Storage And Transport CAS 2023788-19-2
-
Price:
$8/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg*10vials,10mg*10vials,15mg*10vials,20mg*10vials,30mg*10vials,40mg*10vials,60mg*10vials
Fine Chemical Raw Tirzepatide Dual Target Peptide Stable Storage Condition Two Year Shelf Time CAS 2023788-19-2
-
Price:
$8/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg*10vials,10mg*10vials,15mg*10vials,20mg*10vials,30mg*10vials,40mg*10vials,60mg*10vials
High Quality TR60 Tirzepatide CAS No 2023788-19-2 Lab Grade Peptides Powder
-
Price:
$10/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
60mg*10vials
High Purity TR5 Tirzepatide CAS No 2023788-19-2 White Peptides Powder For Lab Research
-
Price:
$10/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg*10vials
- If you want to buy Tirzepatide, then ECHEMI will offer you multi-options. ECHEMI emphasizes on verifying suppliers of Tirzepatide who have registered on the platform to ensure the accuracy and reliability of suppliers. Safe transaction of chemical will be made based on true information. Buy Tirzepatide with 70000+ customers on ECHEMI and make orders now.
- Tirzepatide 2023788-19-2 from ECHEMI are quality guaranteed. Our business partners are with certification, quanlification and so on. Tirzepatide will reach global regulation and requirement of various regions. Customized services of Tirzepatide will provided to customers on ECHEMI.
- We offer reasonable and fair market price of Tirzepatide to provide better products and services. Services of Tirzepatide like trade data and market price and insight can be subscribed on ECHEMI. Efficient order options is the key for supply chain services we offer for you. Buyers are getting help to grow their business internationally on buying Tirzepatide.
- •China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
- •Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
- •Novo Nordisk’s Semaglutide Faces Strong Competition: Eli Lilly’s Tirzepatide Officially Launched in China
- •Eli Lilly Revenue Reaches $31.5 Billion, Up 27%! Tirzepatide and Semaglutide Exceed $20 Billion
- •Novo Nordisk's 2024 Earnings Surge by 23%! Diabetes Drug Sales Skyrocket, but Facing Competition Pressure from Tirzepatide
-
QIngdao Sigma Chemical Co.,Ltd
-
Dongguan Chenguang Technology Co., Ltd.
-
BrightGene Health Technology Co., Ltd
-
Synpeptide Co., Ltd
-
Maintain Biotech Co.Ltd
-
NANJING HANXIN PHARMACEUTICAL TECHNOLOGY
-
Hangzhou Go Top Peptide Biotech Co.,Ltd.
-
Deepharma Peptides/supplement
-
Xiamen Top Health Biochem Tech. Co.,Ltd
-
First Rays Co.,Ltd